DNA ligase IV as a new molecular target for temozolomide.


Temozolomide (TMZ) is a methylating agent used in chemotherapy against glioblastoma. This work was designed to clarify details in repair pathways acting to remove DNA double-strand breaks (DSBs) induced by TMZ. Cultured mouse embryonic fibroblasts were used which were deficient in DSB repair genes such as homologous recombination repair-related genes X-ray… (More)
DOI: 10.1016/j.bbrc.2009.07.045


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.